SCHEMBL7030259

SCHEMBL7030259

CC(=O)CCCC(P(=O)(O)O)P(O)(O)=S

nearest known ligand 0.45

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
FDPS P14324 6/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7032708 0.76 FOLH1 (0.44) FDPS
SCHEMBL9176133 0.74 FDPS (0.54) FDPS
SCHEMBL21611867 0.69 FOLH1 (0.59) FDPS
SCHEMBL3469956 0.68 TYMS (0.55)
SCHEMBL2321372 0.66 FDPS (0.70) FDPS
SCHEMBL20699855 0.66 FDPS (0.75) FDPS
SCHEMBL15305182 0.66 TYMS (0.52)
SCHEMBL8198270 0.65 KDM4E (0.56) FDPS
SCHEMBL18526938 0.65 PAOX (0.42) FDPS
SCHEMBL6422244 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1131327-B1 PROSTAGLANDIN CONJUGATES FOR TREATING OR PREVENTING BONE DISEASES MERCK FROSST CANADA INC (CA) 2003-02-19 EP disclosed
EP-1131327-A1 PROSTAGLANDIN CONJUGATES FOR TREATING OR PREVENTING BONE DISEASE Merck Frosst Canada & Co. (CA) 2001-09-12 EP disclosed
US-6121253-A BONE GROWTH-ENHANCING PROSTAGLANDIN DERIVATIVE CONTAINING BISPHOSPHONATE GROUPS TO INHIBIT BONE RESORPTION; DRUG DELIVERY, SIDE EFFECT REDUCTION, OSTEOPOROSIS MERCK FROSST CANADA & CO. (CA) 2000-09-19 US disclosed
WO-2000031084-A1 PROSTAGLANDIN CONJUGATES FOR TREATING OR PREVENTING BONE DISEASE MERCK FROSST CANADA & CO. (CA) 2000-06-02 WO disclosed